Hospital Clínic de Barcelona at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Clínic de Barcelona takes part in 15 sessions at ESMO 2026 in Madrid. Its program centres on lung and pancreatic cancer, including antibody-drug conjugates and T-cell engagers in lung cancer and RAS-targeted drugs and electric field therapy in pancreatic cancer. Other sessions cover prostate cancer treatment options, side effects of targeted therapies and long-term results in unresectable liver cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Public university hospital in Barcelona, Spain, affiliated with the University of Barcelona, with a linked biomedical research institute.
Talk
Fri Oct 23
14:00–14:15
Smart chemotherapy: ADCs and beyond
SCLC: Can we finally tackle it?
Lung & thoracic cancers
Satellite
Fri Oct 23
18:15–18:20
Welcome and introductions
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with Amsterdam UMC
Genitourinary cancers
Satellite
Fri Oct 23
18:20–19:00
Optimizing treatment for patients living with HR-LPC and with mHSPC – What are the options? What are the benefits?
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with Tallaght University Hospital, University Hospital Essen
Genitourinary cancers
Chair
Sat Oct 24
10:15–11:45
Rapid oral 1: Genitourinary tumours, renal and urothelial
with University Medical Center Utrecht, University of Sheffield
Genitourinary cancers
Abstract
Sat Oct 24
10:30–10:45
Invited Discussant 4738O , 4739O and 4748RO
Rapid oral 1: Genitourinary tumours, renal and urothelial
Genitourinary cancers
Talk
Sat Oct 24
12:00–12:15
Targeted therapies
What oncologists should know about managing toxicities of novel therapies
Nursing & supportive care
Chair
Sat Oct 24
12:00–12:50
What oncologists should know about managing toxicities of novel therapies
with Samsung Medical Center, Gustave Roussy
Nursing & supportive care
Satellite
Sat Oct 24
18:30–20:00
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined
with University of Chicago, University Hospital Cologne
Lung & thoracic cancers
Satellite
Sat Oct 24
19:15–19:40
After Resistance: Emerging ADCs in 2L advanced NSCLC
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined
Lung & thoracic cancers
Satellite
Sat Oct 24
19:40–19:55
Looking Ahead: The Future Puzzle of aNSCLC Treatment
Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined · with University of Chicago, University Hospital Cologne
Lung & thoracic cancers
Talk
Sun Oct 25
10:15–10:35
Presentation by Expert
Tracking genomic evolution and lineage plasticity to guide therapy
Biomarkers & precision oncology
Talk
Sun Oct 25
13:54–14:12
Electric fields for patients with pancreatic cancer: Evidence and research for future combinations
ESMO Colloquium supported by Novocure GmbH - Electric field therapy devices for the treatment of cancer: Expanding treatment paradigms in solid tumour oncology
Satellite
Sun Oct 25
14:00–14:15
The Evolving Algorithm: Sequencing Innovative Strategies
PEAK Medicals - Lung Summit on SCLC: From IO- Standards to the TCE Era
Lung & thoracic cancers
Satellite
Sun Oct 25
14:15–14:30
Faculty Roundtable and Audience Q&A
PEAK Medicals - Lung Summit on SCLC: From IO- Standards to the TCE Era · with Lausanne University Hospital (CHUV), LungenClinic Grosshansdorf, Henry Dunant Hospital Center
Lung & thoracic cancers
Abstract
Sun Oct 25
15:05–15:15
Invited Discussant LBA35 and 1148O
Proffered paper: Prevention, early detection and intervention
Abstract
Sun Oct 25
16:40–16:45
Talk
Mon Oct 26
10:55–11:15
Next-generation therapies: ADCs, small molecules, and rational combinations
Pancreatic cancer: From biology to emerging therapies
Gastrointestinal cancers
Chair
Mon Oct 26
13:00–14:30
Satellite
Mon Oct 26
18:30–18:35
Introduction
Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC · with Clínica Universidad de Navarra, Klinik Floridsdorf
Lung & thoracic cancersGastrointestinal cancers
Satellite
Mon Oct 26
18:30–20:00
Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC
with Clínica Universidad de Navarra, Klinik Floridsdorf
Lung & thoracic cancersGastrointestinal cancers
Satellite
Mon Oct 26
19:15–19:45
Emerging RAS-targeted therapies and treatment strategies for PDAC
Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC
Lung & thoracic cancersGastrointestinal cancers
Satellite
Mon Oct 26
19:45–20:00
Conclusions and Q&A
Revolution Medicines - Advances in RAS-targeted therapies: emerging clinical data and future directions in NSCLC and PDAC · with Clínica Universidad de Navarra, Klinik Floridsdorf
Lung & thoracic cancersGastrointestinal cancers
Chair
Tue Oct 27
09:00–13:00
Scientific Congress Highlights 2
with Gustave Roussy

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Clínic de Barcelona

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction